Lupin gets FDA approval for drug to treat Parkinson’s disease Industry-The Economic Times — October 24, 2017 comments off Lupin is engaged in developing and delivering a wide range of branded and generic formulations, biotechnology products and APIs globally.
Lupin is engaged in developing and delivering a wide range of branded and generic formulations, biotechnology products and APIs globally.